Neural Recording & Interfaces

At the Neural Interfaces Conference, Neuralink disclosed that its Blindsight visual cortical prosthesis incorporates a newly designed 1,680-channel stimulation chip called S2, with plans to implant the first human participant by 2027. This marks a significant advance in write bandwidth for visual prostheses, though still orders of magnitude below what would be needed for high-resolution vision restoration.

According to SEC filings, Neuralink had approximately 26 participants enrolled in its clinical trials by mid-2026, with participants accumulating thousands of cumulative device-use days and no serious device-related adverse events reported to date. This represents a significant scaling from the initial implant in January 2024 and demonstrates feasibility of the N1 system at modest clinical trial scale.

The neurosurgical robotics sector is forecast to grow at 14.1% CAGR through 2030, driven by AI-powered surgical robots, image-guided navigation systems, and increased adoption of minimally invasive techniques including robotic exoscope systems for precision in brain and spine procedures. These advances in surgical delivery systems are critical infrastructure for BCI implantation at scale, reducing procedural risk and enabling broader clinical deployment.

Researchers at Johns Hopkins APL and School of Medicine published a digital holographic imaging system that detects neural tissue deformation through the skull during neural activity, offering a potential path to noninvasive high-resolution brain recording. While promising, the technique requires validation for signal quality and bandwidth compared to invasive methods before it can serve as a serious alternative for reading neural activity at scale.

Medtronic's Hugo system gained FDA clearance in December 2025 for urologic procedures, with the company pursuing additional indications in general surgery and gynecology, marking entry of the world's largest medical device company into soft-tissue robotic surgery. While not BCI-specific, improvements in robotic surgical platforms directly support the technical feasibility and safety profile of implanting next-generation neural interfaces.